Andropeyronie

Peyronie's disease (PD) is an accumulation of collagen in the penis that forms a scar, producing a deformity and pain in the erectile state. This disease affects between 1%-8% of men. The ANDROMEDICAL laboratory announces the great potential of a new combined therapy...

A current study by the American Urological Organization, managed by Dr. Pastuszak of the University of Utah School of Medicine in the USA, revealed that Andropeyronie, the brand of Andromedical penile traction device, is just one of the three most utilized words in...

In the last 5 years different treatments have been proposed for Peyronie's disease. The American Urological Association (AUA) and the Canadian Urological Association (CUA) have proposed a medical protocol based on binding collagenase injections together with daily use...

Our penile traction device for Peyronie´s disease, Andropeyronie, will be at the American Urological Association 2019 Annual Meeting at #1219 stand. We will be grateful for your visit. Our distributors will give you more informations about PTT (penile traction...

What is the Peyronie’s disease? It affects approximately 1 in every 16 men (6%). But most urologists suspect that it is under-reported, and may affect as many as 1 in 10 men (10%). It can occur at any age, although it is seen mostly in the middle‑aged. It is...

2019 CLINICAL STUDY: Penile Traction Therapy and Vacuum Therapy in Peyronie's Disease. Conclusions: Penile Traction Therapy (PTT) and Vacuum Erection Devices (VED) represent viable therapeutic options for managing Peyronie's Disease, with more data currently available...